Avacta Therapeutics (AIM: AVCT), a life sciences company developing next generation peptide drug conjugates (PDC) targeting powerful anti-tumor payloads directly to the tumor, today announced that the Company will present at the Leerink Global Healthcare Conference on Wednesday, March 12, 2025, at 10:00 a.m. ET in Miami.
A live webcast of the presentation will be available in the investors section of the Company’s website at https://avacta.com/investors. The webcast will be archived for at least 30 days following the presentation.